You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
因無法按時更新財務數據 君實生物-B(01877.HK)中止科創板上市申請審核程序
格隆匯 11-01 16:08

格隆匯11月1日丨君實生物-B(01877.HK)公佈,根據中國相關規定(包括《關於科創板發行人財務信息披露有關事項的通知》、《科創板首次公開發行股票註冊管理辦法(試行)》及《上海證券交易所科創板股票發行上市審核規則》),在審企業財務報表超過有效期的,應當及時申請延長有效期,但延長最多不超過一個月。

公司首次申報的財務報表的審計基準日為2019年3月31日,於2019年9月30日超過有效期。根據中國上述規定,公司已於2019年9月27日向上交所提交申請,申請將公司擬上市申請文件中財務報表的有效期延長一個月至2019年10月31日。

由於仍在進行更新財務資料的審計且工作量很大,公司無法於2019年10月31日前完成其財務數據的更新。因此,公司於2019年10月31日向上交所提交中止公司擬上市申請審核程序的申請。待完成財務數據更新後,公司將立即向上交所申請恢復審核程序。目前,公司有關擬上市的申請狀態為"中止"。於中止審核程序期間,公司將繼續進行與擬上市有關的各項工作,而所有相關工作將不受中止審核程序的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account